Empresa Cytori Therapeutics Inc Nasdaq
Acciones
US23283K4022
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 0 | 100,0 % | 5 | 100,0 % | +2.093,30 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 5 | 100,0 % | +2.093,30 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 62 | 01/10/02 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 06/02/20 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 27/07/23 |
Russ Havranek
PRN | Corporate Officer/Principal | - | 01/01/14 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 62 | 01/10/02 |
Richard Hawkins
CHM | Chairman | 74 | 01/12/07 |
Robert Lenk
BRD | Director/Board Member | 76 | 01/03/20 |
J. Clowes
BRD | Director/Board Member | 70 | 01/03/20 |
Greg Petersen
BRD | Director/Board Member | 61 | 14/02/20 |
Director/Board Member | 64 | 01/01/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 5 962 644 | 5 593 929 ( 93,82 %) | 258 425 ( 4,334 %) | 93,82 % |
Información de la empresa
Plus Therapeutics, Inc.
4200 Marathon Boulevard Suite 200
78756, Austin
+737 255 7194
http://www.plustherapeutics.com![Dirección Cytori Therapeutics Inc](https://cdn.zonebourse.com/static/address/43482248.png)
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+25,83 % | 47,96 mil M | |
+0,69 % | 42,45 mil M | |
+44,42 % | 41,47 mil M | |
+30,52 % | 31,6 mil M | |
+22,30 % | 28,63 mil M | |
-6,35 % | 28,03 mil M | |
+49,25 % | 14,56 mil M | |
+49,18 % | 14,14 mil M | |
+3,45 % | 12,58 mil M |